Page last updated: 2024-08-25

chitosan and Pneumococcal Infections

chitosan has been researched along with Pneumococcal Infections in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, B; Dai, WJ; Fan, XY; Xu, JH1
Chen, B; Dai, W; Fan, X; Li, Z; Wang, Z; Xu, J1

Other Studies

2 other study(ies) available for chitosan and Pneumococcal Infections

ArticleYear
Mucosal immunization with PsaA protein, using chitosan as a delivery system, increases protection against acute otitis media and invasive infection by Streptococcus pneumoniae.
    Scandinavian journal of immunology, 2015, Volume: 81, Issue:3

    Topics: Adhesins, Bacterial; Administration, Intranasal; Animals; Antibodies, Bacterial; Chitosan; Drug Carriers; Female; Immunization; Immunoglobulin A; Immunoglobulin G; Interferon-gamma; Interleukin-17; Interleukin-4; Lipoproteins; Mice; Mice, Inbred BALB C; Nanoparticles; Otitis Media; Pneumococcal Infections; Pneumococcal Vaccines; Streptococcus pneumoniae; Vaccines, Conjugate

2015
Intranasal vaccination with chitosan-DNA nanoparticles expressing pneumococcal surface antigen a protects mice against nasopharyngeal colonization by Streptococcus pneumoniae.
    Clinical and vaccine immunology : CVI, 2011, Volume: 18, Issue:1

    Topics: Adhesins, Bacterial; Administration, Intranasal; Animals; Cell Line; Chitosan; DNA; Female; Humans; Lipoproteins; Mice; Mice, Inbred BALB C; Nanoparticles; Nasopharynx; Pneumococcal Infections; Pneumococcal Vaccines; Streptococcus pneumoniae; Vaccination

2011